Novartis CEO Vas Narasimhan joins 'Money Movers' to discuss the company's latest earnings report, policies around drug pricing, and more. Got a confidential news tip? We want to hear from you. Sign up ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果